UK researchers switch off genes that trigger cervical cancerBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7364.563 (Published 14 September 2002) Cite this as: BMJ 2002;325:563
- Susan Mayor
UK researchers have reported that they have been able to switch off a human papillomavirus gene that triggers cervical cancer, using a new highly targeted technique—RNA interference.
A team at the University of York reported last week that RNA interference, which works by selectively “silencing” homologous genes, completely eliminated all human cervical cancer cells in vitro yet left healthy cells unharmed (Oncogene 2002;21: 6041-8)
This was the first evidence that RNA interference can turn off genes of infectious viruses in tumour cells, rendering them harmless.
The researchers chose human cervical cancer cells that are …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.